ACR Advises Changes to Washington State PAD Report
ACR urged the WA State Health Technology Clinical Committee to not act on the draft report that would limit coverage of endovascular procedures for PAD.
Read moreMain Content
More Than 200 FDA Cleared AI Medical Imaging Products Now Available
Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
Related ACR News
ACR Releases Impact Tables for 2026 MPFS Proposed Rule
The tables cover specific proposed changes in reimbursement rates between 2025 and 2026 for each CPT® code.
Read moreTake Action: Contact Your US Senators to Cosponsor ROOT Act
Support the ROOT Act—Senate cosponsors needed to fix CMS issues with imaging AUC under PAMA. College member advocacy is key.
Read more